WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.20
+1.90 (2.56%)
Feb 21, 2025, 1:38 PM CST

WeLeader Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021
Period Ending
Feb '25 Dec '22 Dec '21
Debt / Equity Ratio
0.921.090.79
Debt / EBITDA Ratio
2.142.301.14
Debt / FCF Ratio
--1.30
Asset Turnover
-0.83-
Inventory Turnover
-12.54-
Quick Ratio
-0.891.13
Current Ratio
-1.041.29
Return on Equity (ROE)
-30.65%-
Return on Assets (ROA)
-9.80%-
Return on Capital (ROIC)
-12.24%-
Return on Capital Employed (ROCE)
-16.75%25.47%
Payout Ratio
22.99%6.35%21.14%
Buyback Yield / Dilution
-32.55%-8.28%-
Total Shareholder Return
-29.53%-8.28%-
Source: S&P Capital IQ. Standard template. Financial Sources.